Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 69, Issue 3, 2000, Pages 313-318

  Soliveri, Paola ^a   Monza, Daniela ^a   Paridi, Dominga ^a   Carella, Francesco ^a   Genitrini, Silvia ^a   Testa, Daniela ^a   Girotti, Floriano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Neuropsychological follow up; Parkinson's disease; Progressive supranuclear palsy; Striatonigral degeneration type multisystem atrophy

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; COGNITIVE DEFECT; COMPARATIVE STUDY; DETERIORATION; DISEASE COURSE; DISEASE SEVERITY; EVALUATION AND FOLLOW UP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RATING SCALE; VERBAL COMMUNICATION; VISION TEST;

EID: 0033898821     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.69.3.313     Document Type: Article

References (52)

1. Cohen S, Freedman M. Cognitive and behavioural changes in the Parkinson-plus syndromes. In: Weiner WJ, Lang AE, eds. Advances in neurology. (Behavioural neurology of movement disorders.) Vol 65. New York: Raven Press, 1995:139-57.
2. Pillon B, Dubois B, Agid Y. Testing cognition may contribute to the diagnosis of movement disorders. Neurology 1996;46:329-34.
3. Lees AR, Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983;106:257-70.
4. Pillon B, Gouider-Khouja N, Deweer B, et al. Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1995;58:174-9.
5. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994;57: 79-88.
6. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-75.
7. Levin BE, Katzen HL. Early cognitive changes and non-dementing behavioural abnormalities in Parkinson's disease. In: Behavioural Neurology of Movement Disorders. Weiner WJ, Lang AE, eds. Advances in Neurology. Vol 65. New York: Raven Press; 1995:85-95.
8. Mohr E, Mendis T, Grimes JD. Late cognitive changes in Parkinson's disease with an emphasis on dementia. In: Weiner WJ, Lang AE, eds. Advances in Neurology. (Behavioural Neurology of Movement Disorders.) Vol 45. New York: Raven Press, 1995:97-113.
9. McRae A. Neurotransmitters and pharmacology of the basal ganglia. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1998:47-66.
10. McKieth IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:113-24.
11. Portin R, Rinne UK. Neuropsychological responses of parkinsonian patients to long-term levodopa treatment. In: Rinne UK, Klinger M, Stamm G, eds. Parkinson's disease-current progress, problems and management. Amsterdam: Elsevier, 1980:271-304.
12. Growdon J, Corkin S. Cognitive impairments in Parkinson's disease. Adv Neurol 1986;45:383-91.
13. Starkstein SE, Mayberg HS, Leiguarda R, et al. A prospective longitudinal study of depression, cognitive decline and physical impairment in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:377-82.
14. Bayles KA, Tomoeda CK, Wood JA, et al. Change in cognitive function in idiopathic Parkinson's disease. Arch Neurol 1996;53:1140-6.
15. Palazzini E, Soliveri P, Filippini G, et al. Progression of motor and cognitive impairment in Parkinson's disease. J Neurol 1995;242:535-40.
16. Maher ER, Smith EM, Lees AJ. Cognitive deficits in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). J Neurol Neurosurg Psychiatry 1985;48: 1234-9.
17. Pillon B, Dubois B, Ploska A, et al. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology 1991;41:634-43.
18. Monza D, Soliveri P, Radice D, et al. Cognitive dysfunction and impaired organisation of complex motility in degenerative parkinsonian syndromes. Arch Neurol 1998;55:372-8.
19. Pillon B, Dubois B. Cognitive and behavioural impairments. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:223-39.
20. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, et al, eds. Recent developments in Parkinson's disease. VoI II. New Jersey: MacMillan Healthcare Information; 1987:153-63.
21. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
22. Quinn N. Multiple system atrophy: the nature of the beast. J Neurol Neurosurg Psychiatry 1989;20:78-89.
23. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
24. Savoiardo M, Grisoli M. Magnetic resonance imaging of movement disorders. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1998:967-90.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association, 1994.
26. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971;9:97-113.
27. Folstein MF, Folstein SE, McHugh PR. Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
28. Raven JC. Guide to using the colored progressive matrices. London: HK Lewis, 1965.
29. Randt CT, Brown ER, Osborne DP. A memory test for longitudinal measurement of mild to moderate deficits. Clin Neuropsychol 1980;2:184-94.
30. Novelli G, Papagno C, Capitani E, et al. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Archivio di Psicologia Neurologia e Psichiatria. 1986;47:477-506.
31. Benton AL, Varney NR, Hamsher K de S. Visuo-spatial judgment: a clinical test. Arch Neurol 1978;35:364-7.
32. Nelson HE. Modified card sorting test sensitive to frontal lobe defects. Cortex 1976;12:313-24.
33. Basso A, Capitani E, Laiacona M. Raven's coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol 1987;2:189-94.
34. Measso G, Cavarzeran F, Zappalà G, et al. The mini mental state examination normative study of an Italian random sample. Developmental Neuropsychology 1993;9:77-85.
35. Spinnler H, Tognoni G. Gruppo italiano per lo studio neuropsicologico dell'invecchiamento. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987;(suppl 8).
36. Agid Y, Javoy-Agid F, Ruberg M, et al. Progressive supranuclear palsy: anatomoclinical and biochemical considerations. In: Parkinson's disease. Yahr MD, Bergmann KJ, eds. Advances in neurology. Vol 45. New York: Raven, 1986:191-206.
37. Heilman KM, Valenstein E, Watson RT. Neglect. In: Asbury AK, McKhann GM, McDonald WI, eds. Diseases of the nervous system clinical neurobiology. 2nd ed. Philadelphia: WB Saunders, 1192:768-79.
38. Lantos P.L. The neuropathology of progressive supranuclear palsy. J Neural Transm Suppl 1994;42:137-52.
39. Jellinger KA, Bancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press; 1992:45-87.
40. Verny M, Duyckaerts C, Agid Y, et al. The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 1996;119: 1123-36.
41. Golbe LJ, Davis PH, Schoenberg BS, et al. The prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-4.
42. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;61:615-20.
43. Wenning GK, Ben-Shlomo BY, Megalhāes M, et al. Clinical features and natural history of multiple system atrophy: an analysis of 100 cases. Brain 1994;117:835-45.
44. Testa D, Filippini G, Farinotti M, et al. Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J Neurol 1996;243:401-4.
45. Eslinger PJ, Grattan LM. Frontal lobe and fronto-striatal substrates for different forms of human cognitive flexibility. Neuropsychologia 1993;31:17-28.
46. Grafman J, Litvan I, Gomez C, et al. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990;47:553-8.
47. Dubois B, Pillon B, Legault F, et al. Slowing of cognitive processing in progressive supranuclear palsy: a comparison with Parkinson's disease. Arch Neurol 1988;45:1194-9.
48. Guillery RW, Feig SL, Lozsádi DA. Paying attention to the thalamic reticular nucleus. Trends Neurosci 1998;21:28-32.
49. Posner MI, Dehaene S. Attentional networks. Trends Neurosci 1994;17:75-9.
50. Kimura D, Barnett HJM, Burkhart G. The psychological test pattern in progressive supranuclear palsy. Neuropsychologia 1981;19:301-6.
51. Papp MI, Lantos PL. The distribution of oligodendroglial inclusion in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-43.
52. Fearnley JM, Lees AJ. Striatonigral degeneration: a clinicopathological study. Brain 1990;113:1823-42.